Washington University in St. Louis

Long term variability of Cygnus X-1: VIII. A spectral-timing look at low energies with NICER (2024) König O, Mastroserio G, Dauser T, Méndez M, Wang J, García JA, Steiner JF, et al. Journal article A bistable inhibitory optoGPCR for multiplexed optogenetic control of neural circuits (2024) Wietek J, Nozownik A, Pulin M, Saraf-Sinik I, Matosevich N, Gowrishankar R, Gat A, et al. Journal article Astronomy’s climate emissions: Global travel to scientific meetings in 2019 (2024) Gokus A, Jahnke K, Woods PM, Moss VA, Ossenkopf-Okada V, Sacchi E, Stevens AR, et al. Journal article Vulnerabilities in social anxiety: Integrating intra- and interpersonal perspectives (2024) Ginat-Frolich R, Gilboa-Schechtman E, Huppert JD, Aderka IM, Alden LE, Bar-Haim Y, Becker ES, et al. Journal article, Review article Rapid variability of Markarian 421 during extreme flaring as seen through the eyes of XMM-Newton (2024) Gokus A, Wilms J, Kadler M, Dorner D, Nowak MA, Kreikenbohm A, Leiter K, et al. Journal article Hybrid zinc oxide nanocoating on titanium implants: Controlled drug release for enhanced antibacterial and osteogenic performance in infectious conditions (2024) Zhou J, Wang H, Virtanen S, Witek L, Dong H, Thanassi D, Shen J, et al. Journal article Cranioencephalic functional lymphoid units in glioblastoma (2024) Dobersalske C, Rauschenbach L, Hua Y, Berliner C, Steinbach A, Grüneboom A, Kokkaliaris KD, et al. Journal article Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions (2024) Dareng EO, Coetzee SG, Tyrer JP, Peng PC, Rosenow W, Chen S, Davis BD, et al. Journal article Characterization of hyperpolarization-activated cyclic nucleotide-gated channels in oligodendrocytes. (2024) Lyman KA, Han Y, Robinson AP, Weinberg SE, Fisher DW, Heuermann RJ, Lyman RE, et al. Journal article A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 (2024) Hughes BG, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, et al. Journal article